28 | Messenger RNA (mRNA)IBA
04/2022
-
02/2002 |
23 | Growth Hormone-Releasing Hormone (Somatotropin Releasing Hormone)IBA
04/2022
-
01/2002 |
20 | Gonadotropin-Releasing Hormone (GnRH)FDA Link
01/2020
-
09/2003 |
16 | Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
12/2020
-
02/2002 |
16 | BombesinIBA
10/2012
-
10/2003 |
16 | AN 204 (AN 201)IBA
06/2007
-
02/2002 |
15 | Proteins (Proteins, Gene)FDA Link
01/2018
-
04/2005 |
13 | LigandsIBA
04/2022
-
10/2002 |
12 | Doxorubicin (Adriamycin)FDA LinkGeneric
05/2013
-
04/2003 |
11 | LHRH Receptors (Gonadotropin-Releasing Hormone Receptor)IBA
01/2020
-
09/2003 |
11 | AndrogensIBA
04/2012
-
02/2002 |
11 | AN 238IBA
07/2006
-
02/2002 |
10 | Somatostatin Receptors (Somatostatin Receptor)IBA
06/2018
-
02/2002 |
10 | Gastrin-Releasing PeptideIBA
02/2013
-
01/2005 |
9 | AN 215IBA
07/2006
-
10/2003 |
8 | somatotropin releasing hormone receptorIBA
01/2017
-
06/2002 |
8 | Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2012
-
02/2005 |
7 | lysine(6)-doxorubicin LHRHIBA
01/2020
-
09/2003 |
7 | RC 121IBA
08/2010
-
02/2002 |
7 | AN 207IBA
06/2007
-
04/2005 |
5 | Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
02/2013
-
08/2005 |
5 | MZ-J-7-138IBA
04/2012
-
07/2005 |
5 | Insulin-Like Growth Factor I (IGF-1)IBA
03/2006
-
04/2002 |
4 | Hca(6)-Leu(13)-psi(CH2N)-Tac(14)- bombesin(6-14)IBA
10/2012
-
01/2005 |
4 | cetrorelix (Cetrotide)FDA Link
04/2012
-
09/2007 |
4 | Peptides (Polypeptides)IBA
03/2011
-
07/2006 |
4 | Insulin-Like Growth Factor II (Somatomedin A)IBA
12/2008
-
11/2003 |
4 | MZ-J-7-118IBA
09/2007
-
01/2005 |
4 | Protein Isoforms (Isoforms)IBA
08/2006
-
06/2002 |
3 | Har(29)- Arg(28) Nle(27) Orn(21) His(20) Orn(12,) Abu(15) His(11) Tyr(Me)(10) Har(9) Ala(8) Fpa(5,6) Arg(2) (PhAc-Ada)(0)-Tyr(1) GHRH(1-29)NH2IBA
01/2022
-
02/2012 |
3 | Hormones (Hormone)IBA
01/2018
-
10/2004 |
3 | Epidermal Growth Factor (EGF)IBA
09/2007
-
08/2005 |
3 | RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
06/2007
-
10/2003 |
3 | ErbB Receptors (EGF Receptor)IBA
02/2007
-
10/2003 |
3 | JV 1-38IBA
08/2006
-
11/2003 |
2 | Antineoplastic Agents (Antineoplastics)IBA
01/2022
-
10/2005 |
2 | Human Growth Hormone (Saizen)FDA LinkGeneric
01/2017
-
10/2004 |
2 | Vasoactive Intestinal Peptide Receptors (Vasoactive Intestinal Peptide Receptor)IBA
10/2011
-
04/2002 |
2 | PhAcTyr(1)- Arg(2)- P(H)e(4- CL)(6)- Ala(8)- Tyr(Me)(10)- His(11)- Abu(15)- His(20)- Nle(27)- Arg(28)- HLCr(29)- GHRH(1-29)NH2IBA
10/2009
-
02/2007 |
2 | Estrogens (Estrogen)FDA Link
08/2009
-
09/2003 |
2 | Docetaxel (Taxotere)FDA Link
02/2007
-
09/2006 |
2 | Member 1 Subfamily B ATP Binding Cassette TransporterIBA
07/2006
-
11/2005 |
2 | Membrane Transport Proteins (Biological Pump)IBA
11/2005
-
09/2005 |
2 | Triptorelin Pamoate (Trelstar)FDA Link
08/2005
-
10/2003 |
2 | Insulin-Like PeptidesIBA
02/2004
-
11/2003 |
2 | pentetreotide (OctreoScan)FDA Link
05/2003
-
04/2003 |
2 | vapreotideIBA
05/2003
-
04/2002 |
2 | Membrane Proteins (Integral Membrane Proteins)IBA
10/2002
-
06/2002 |
1 | 1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA
04/2024 |
1 | Glucose (Dextrose)FDA LinkGeneric
04/2024 |
1 | CD13 Antigens (Alanine Aminopeptidase)IBA
04/2024 |
1 | Complementary DNA (cDNA)IBA
01/2023 |
1 | NeuropeptidesIBA
12/2020 |
1 | Hypothalamic HormonesIBA
01/2018 |
1 | MR 356IBA
02/2014 |
1 | N-Me-Tyr1,D-Ala2,Asn8,Arg29-NHCH3-JI-38IBA
02/2014 |
1 | JI-38IBA
02/2014 |
1 | Gonadal Steroid Hormones (Sex Hormones)IBA
05/2013 |
1 | ImmunosorbentsIBA
02/2012 |
1 | EnzymesIBA
02/2012 |
1 | matrigelIBA
02/2012 |